Issam Awad to Hemangioma, Cavernous
This is a "connection" page, showing publications Issam Awad has written about Hemangioma, Cavernous.
Connection Strength
3.766
-
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Neurosurgery. 2021 02 16; 88(3):686-697.
Score: 0.705
-
A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus. J Clin Neurosci. 2011 Jun; 18(6):846-8.
Score: 0.355
-
From mutant mice to "vascular permeability therapy" in cavernous angiomas? Neurosurgery. 2009 May; 64(5):N10.
Score: 0.311
-
Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003 Feb; 52(2):465-77; discussion 477-8.
Score: 0.202
-
Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery. 2002 Jan; 50(1):110-5; discussion 115-6.
Score: 0.187
-
Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth. J Magn Reson Imaging. 2022 05; 55(5):1440-1449.
Score: 0.184
-
Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. J Cereb Blood Flow Metab. 2021 11; 41(11):2944-2956.
Score: 0.180
-
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020 05 27; 11(1):2659.
Score: 0.168
-
Symptomatic Brain Hemorrhages from Cavernous Angioma After Botulinum Toxin Injections, a Role of TLR/MEKK3 Mechanism? Case Report and Review of the Literature. World Neurosurg. 2020 Apr; 136:7-11.
Score: 0.163
-
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
Score: 0.162
-
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease. Transl Stroke Res. 2020 06; 11(3):365-376.
Score: 0.159
-
Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight. 2019 06 20; 4(12).
Score: 0.157
-
A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
Score: 0.152
-
Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery. 1996 Jun; 38(6):1265-71.
Score: 0.127
-
Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct; 37(4):591-605.
Score: 0.121
-
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6620-4.
Score: 0.119
-
Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
Score: 0.104
-
Mutational analysis of 206 families with cavernous malformations. J Neurosurg. 2003 Jul; 99(1):38-43.
Score: 0.052
-
A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996 Apr 11; 334(15):946-51.
Score: 0.031
-
Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia. 1994; 35 Suppl 6:S30-43.
Score: 0.027
-
Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery. 1993 Oct; 33(4):547-54; discussion 554-5.
Score: 0.026
-
Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations. Neurosurgery. 1993 May; 32(5):876-8.
Score: 0.026
-
Brainstem cavernous malformations: 1390 surgical cases from the literature. World Neurosurg. 2013 Jul-Aug; 80(1-2):89-93.
Score: 0.024
-
Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
Score: 0.023